nedocromil sodium
There were significant       differences in the changes from baseline values during the last six weeks of       treatment in favour of nedocromil sodium compared with placebo in the primary       variables of daytime asthma and night time asthma, morning and evening PEF, and       the usage of rescue inhaled bronchodilators; 53% of patients reported nedocromil        sodium to be very or moderately effective compared with 44% placebo.
There were significant       differences in the changes from baseline values during the last six weeks of       treatment in favour of  @SUBJECT$   @PREDICAT$  with  @OBJECT$  in the primary       variables of daytime asthma and night time asthma, morning and evening PEF, and       the usage of rescue inhaled bronchodilators; 53% of patients reported nedocromil        sodium to be very or moderately effective compared with 44% placebo.